BATF and cancer: Some of the notable increases seen in cancer patients included subsets of T cells expressing basic leucine zipper transcription factor, ATF-like (BATF), PD-L1 and CTLA-4, which are inhibitory markers involved in immune checkpoint pathways and are increased upon T cell activation [13, 15].